CPRB News - April 2024 / avril 2024

April 23, 2024
 
 

Accreditation Policies and Procedures Update 

The Canadian Pharmacy Residency Board (CPRB) has worked on updates to the Accreditation Policies and Procedures over the last year.  These 2024 updates are now posted to the CPRB website. Highlights of the key changes include the addition of the accreditation award definitions and modifications to the definitions and categories for residency programs.  In addition, the CPRB has updated the Notification of Intent form that new residency programs wishing to request accreditation must complete and submit to the CPRB coordinator at cprb@cshp.ca.  This PDF Fillable form can also be found on the CPRB website.

Pfizer Award Winners – Year 1

The Pharmacy Practice Residency Award recognizes Year 1 Pharmacy Residents whose major residency project (typically a research project) are judged to be most deserving in terms of significant innovation, practical application, and/or development in an institutional pharmacy practice setting. Winners receive a $1,000 cash prize.
To be eligible, each candidate must:
  • Be a current member of CSHP and must have been a member of CSHP at the time the residency was completed;
  • Be currently enrolled in, or one-year post-completion, of a CPRB-accredited (or accreditation-pending) Year 1 pharmacy residency program in the province of the CSHP branch administering the award;
  • Submit an award application to the CSHP branch in the province in which the residency was completed.   

The winners of the 2023 Pharmacy Practice Residency Award, sponsored by Pfizer Canada are listed below.

British Columbia Branch (5 awards)

1. Kathleen Lau (Lower Mainland Pharmacy Services)

  • The Effect of Infographic Counselling Aid on Patient Treatment Satisfaction and Understanding in Heart Failure with Reduced Ejection Fraction (INFOSat-HF): A Prospective Single- Arm Before-and-After Study 

2. Amy Jradi (Northern Health)

  • Pharmacists’ Perceived Confidence and Efficacy in Managing Patients with Suicidal Ideation-An Assessment of a Pilot Workshop 

3. Zoe Hopkins  (Island Health)

  • A Retrospective Evaluation of Pulmonary Embolism and Thrombolysis in patients admitted to the Intensive Care Unit (REPEAT ICU) 

4. Alison Bentley (Island Health)

  • Counting the Carbon: Quantifying Financial and Environmental Implications of Wasted Inhaler Doses in the Hospital Setting 

5. Franklin Hu (Lower Mainland Pharmacy Services)

  • Patient-reported Outcomes and Experience following Initiation of Elexacaftor/Tezacaftor/Ivacaftor for the Treatment of Cystic Fibrosis 

Alberta Branch (1 award)

6. Christina Watts (Alberta Health Services)

  • Pharmacist Telephone Follow-up for Antineoplastic Agents used in Hematologic Cancers 

Saskatchewan Branch (1 award)
7. Calvin Yee and Habiba Elshorbagy (Saskatchewan Health Authority)

  • Entrust the Process: Development and Implementation of an Entrustable Professional Activity Assessment Tool for Pharmacy Students Educating Patients on Oral Anticoagulant 

Manitoba Branch (1 award)
8. Danielle D'Entremont  (Winnipeg Regional Health Authority)

  • Characterizing Empiric Antibiotic Therapy for Pediatric Cellulitis at a Hospital with a High Prevalence of MRSA 

New Brunswick and Nova Scotia Branches (1 award)
9. Austin Harding (Nova Scotia Health Authority)

  • Identifying Influences on Decision-Making Regarding Antipsychotic Prescribing to Long-Term Care Residents with Dementia: A Systematic Review of Qualitative Literature

Newfoundland and Labrador Branch (1 award)
10. Courtney Donovan (Newfoundland and Labrador Health Services)

  • A quality-of-life assessment and personal recount of patients currently receiving Cystic Fibrosis therapy with elexacaftor/tezacaftor/ivacaftor 

Ontario Branch (4 awards)
11. Sarah Tessier (The Ottawa Hospital)

  • Assessing Hospital Pharmacists’ Clinical Scope of Practice in Ontario 

12. Kadaajah Johnson-Louis (Humber River Hospital)

  • Prospective Comparison of Vancomycin Area Under the Curve and Trough Concentration in Specific Populations

13. Gabrielle Busque (Unity Health Toronto)

  • Describing and Evaluating the Clinical Pharmacist's Role in a Canadian Multiple Sclerosis Clinic

14.  Mishka Danchuk-Lauzon (Sunnybrook Health Sciences Centre)

  • Cannabis Prevalence and Patterns of Use in Cancer Patients Receiving Systemic Anticancer Treatment at Sunnybrook Odette Cancer Centre: A Prospective Survey Study

2023 Graduates

Congratulations to the 2022-2023 residents who successfully completed the Accredited & Accreditation-Pending (Year 1 and Advanced Practice – Year 2) Pharmacy Residency Programs!  


Nouvelles du CCRP – Mars 2024  

23 avril, 2024  

Mise à jour des politiques et procédures d'agrément 

Au cours de la dernière année, le Conseil canadien de la résidence en pharmacie (CCRP) a travaillé à la mise à jour des politiques et procédures d'agrément. Ces mises à jour pour 2024 sont maintenant affichées sur le site Web du CCRP (à noter, la version française sera disponible sous peu).  Les principaux changements comprennent l'ajout des définitions des catégories de certificats d'agrément, ainsi que des modifications aux définitions et aux catégories des programmes de résidence.  En outre, le CCRP a mis à jour le formulaire d’Avis d’intention que les nouveaux programmes de résidence souhaitant demander l'agrément doivent remplir et soumettre au coordonnateur du CCRP à l'adresse cprb@cshp.ca.  Ce formulaire PDF remplissable est également disponible sur le site web du CCRP.

Lauréats des prix Pfizer – Année 1

Le prix de la résidence en pratique pharmaceutique récompense les résidents en pharmacie (Année 1) dont les principaux projets de résidence (typiquement un projet de recherche) sont jugés les plus méritants en termes d'innovation, d'application pratique et/ou de développement d'une pratique pharmaceutique institutionnelle.  Les lauréats reçoivent un prix de 1 000 dollars. 
Pour être éligible, chaque candidat doit:

  • Être membre actuel de la SCPH et avoir été membre de la SCPH au moment où la résidence a été complétée ;
  • Être actuellement inscrit à un programme de résidence en pharmacie (Année 1) agréé (ou en attente d'agrément) dans la province de la division de la SCPH qui administre le prix, ou avoir terminé ce programme depuis un an ; 
  • Soumettre une demande de prix à la division de la SCPH de la province dans laquelle la résidence a été complétée.    

Les lauréats du Prix de la résidence en pratique pharmaceutique 2023, parrainé par Pfizer Canada, sont énumérés ci-dessous.

Division Colombie-Britannique (5 prix) 

1. Kathleen Lau (Lower Mainland Pharmacy Services)

  • The Effect of Infographic Counselling Aid on Patient Treatment Satisfaction and Understanding in Heart Failure with Reduced Ejection Fraction (INFOSat-HF): A Prospective Single- Arm Before-and-After Study 

2. Amy Jradi (Northern Health)

  • Pharmacists’ Perceived Confidence and Efficacy in Managing Patients with Suicidal Ideation-An Assessment of a Pilot Workshop 

3. Zoe Hopkins  (Island Health)

  • A Retrospective Evaluation of Pulmonary Embolism and Thrombolysis in patients admitted to the Intensive Care Unit (REPEAT ICU) 

4. Alison Bentley (Island Health)

  • Counting the Carbon: Quantifying Financial and Environmental Implications of Wasted Inhaler Doses in the Hospital Setting 

5. Franklin Hu (Lower Mainland Pharmacy Services)

  • Patient-reported Outcomes and Experience following Initiation of Elexacaftor/Tezacaftor/Ivacaftor for the Treatment of Cystic Fibrosis 

Division Alberta (1 prix) 

6. Christina Watts (Alberta Health Services)

  • Pharmacist Telephone Follow-up for Antineoplastic Agents used in Hematologic Cancers 

Division Saskatchewan (1 prix) 
7. Calvin Yee and Habiba Elshorbagy (Saskatchewan Health Authority)

  • Entrust the Process: Development and Implementation of an Entrustable Professional Activity Assessment Tool for Pharmacy Students Educating Patients on Oral Anticoagulant 

Division Manitoba (1 prix) 
8. Danielle D'Entremont  (Winnipeg Regional Health Authority)

  • Characterizing Empiric Antibiotic Therapy for Pediatric Cellulitis at a Hospital with a High Prevalence of MRSA 

Divisions Nouveau-Brunswick et Nouvelle-Écosse (1 prix) 
9. Austin Harding (Nova Scotia Health Authority)

  • Identifying Influences on Decision-Making Regarding Antipsychotic Prescribing to Long-Term Care Residents with Dementia: A Systematic Review of Qualitative Literature

Division Terre-Neuve-et-Labrador (1 prix) 
10. Courtney Donovan (Newfoundland and Labrador Health Services)

  • A quality-of-life assessment and personal recount of patients currently receiving Cystic Fibrosis therapy with elexacaftor/tezacaftor/ivacaftor 

Division Ontario (4 prix) 
11. Sarah Tessier (The Ottawa Hospital)

  • Assessing Hospital Pharmacists’ Clinical Scope of Practice in Ontario 

12. Kadaajah Johnson-Louis (Humber River Hospital)

  • Prospective Comparison of Vancomycin Area Under the Curve and Trough Concentration in Specific Populations 

13. Gabrielle Busque (Unity Health Toronto)

  • Describing and Evaluating the Clinical Pharmacist's Role in a Canadian Multiple Sclerosis Clinic

14.  Mishka Danchuk-Lauzon (Sunnybrook Health Sciences Centre)

  • Cannabis Prevalence and Patterns of Use in Cancer Patients Receiving Systemic Anticancer Treatment at Sunnybrook Odette Cancer Centre: A Prospective Survey Study

Diplômés 2023

Félicitations aux résidents de 2022-2023 qui ont terminé avec succès les programmes de résidence en pharmacie agréés ou en attente d'agrément (année 1 et pratique avancée - année 2)!